IONIS PHARMACEUTICALS INC (IONS) Stock Profile — Insider Trades & Financials

Revenue$203.3M

Net Income-$229.4M

EPS$0.70

Market Cap$12.2B

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Brett P. Monia

CEO & Executive Director

Ionis Pharmaceuticals, Inc. is a biotechnology company that specializes in discovering and developing antisense therapy, as well as RNA interference and CRISPR therapeutics. The company was founded in 1989 is based in Carlsbad, California. The company was previously known as Isis Pharmaceuticals until December 2015.

Employees: 1,069
Headquarters: CARLSBAD, CA, United States
Website: www.ionispharma.com

Peer ComparisonRevenue ($B)

▾

⚡

Core Efficiency

ROE?

-46.90%

ROA?

-6.51%

D/E Ratio?

6.20

Op. Margin?

-105.47%

📊

Profitability Ratios

Net Margin?

-112.82%

Loading company sections...

IONIS PHARMACEUTICALS INC

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness